Official UK procurement notice
WIRRAL UNIVERSITY TEACHING HOSPITAL (EFIN) - WT2023-24 - PIPERACILLIN 4G TAZOBACTAM 500MG (100ML) Infusion, MORPHINE SULFATE (PCA) 100 mg in 100mL Injection (100ML) - 3 years
Authority: Western Health & Social Care Trust (Central government)
What is being bought
Published requirement descriptionSupply of PIPERACILLIN 4G TAZOBACTAM 500MG (100ML) Infusion, MORPHINE SULFATE (PCA) 100 mg in 100mL Injection to meet clinical need in the Western Trust for 3 YEARS
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 11 Sept 2023, 10:50 BST
- Last source update
- 11 Sept 2023, 10:50 BST
- Authority reference
WT2023-24- FTS notice number
2023/S 000-026773- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03fba0Find a Tender
- Why no open competition
- Additional deliveries by the original supplier ordered under the strict conditions stated in the directive
- Published justification
Regulation 32(5)(b) permits the use of the negotiated procedure without prior publication for public supply contracts for additional deliveries by the original supplier, where a change of supplier would oblige the contracting authority to acquire supplies having different technical characteristics which would result in incompatibility or disproportionate technical difficulties in operation and maintenance.
The Western Health and Social Care Trust requires the purchase of PIPERACILLIN 4G TAZOBACTAM 500MG (100ML) Infusion, MORPHINE SULFATE (PCA) 100 mg in 100mL Injection (100ML) which are required for continuity of care of patients. A change in product is not clinically recommended and may compromise patient treatment.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Wirral University Teaching Hospital NHS Foundation Trust (WUTH) | £196,610 † | — | Awarded |
Contracts
WIRRAL UNIVERSITY TEACHING HOSPITAL (EFIN) - WT2023-24 - PIPERACILLIN 4G TAZOBACTAM 500MG (100ML) Infusion, MORPHINE SULFATE (PCA) 100 mg in 100mL Injection (100ML) - 3 years · Wirral University Teaching Hospital NHS Foundation Trust (WUTH)
- Signed
- 30 Aug 2023
- Value
- £196,610
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- WIRRAL UNIVERSITY TEACHING HOSPITALAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.